Carlsmed, Inc. (CARL) Appoints New CFO, Reaffirms FY26 Revenue Outlook
Carlsmed appointed Richard Heppenstall as CFO, succeeding Leo Greenstein, and reaffirmed FY26 revenue guidance of $74—$78M.Material DetailsContext by AI AnalystThis is a management transition with steady guidance, reinforcing a growth narrative tied to reimbursement and launches. A catalyst would b…